Provectus Biopharmaceuticals Inc (PVCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Operating Expenses | 1,902 | 1,358 | 2,095 | 2,699 | 2,625 |
| Operating Income | -1,902 | -1,358 | -2,095 | -2,699 | -2,625 |
| Interest Expense | 273 | 256 | 235 | 207 | 276 |
| Other Income | -13 | 5 | 873 | 6 | 179 |
| Pre-tax Income | -2,188 | -1,609 | -1,456 | -2,900 | -2,722 |
| Net Income Continuous | -2,188 | -1,609 | -1,456 | -2,900 | -2,722 |
| Net Income | $-2,188 | $-1,609 | $-1,456 | $-2,900 | $-2,722 |
| EPS Basic Total Ops | -0.01 | 0.00 | 0.00 | -0.01 | -0.01 |
| EPS Basic Continuous Ops | -0.01 | 0.00 | 0.00 | -0.01 | -0.01 |
| EPS Diluted Total Ops | -0.01 | 0.00 | 0.00 | -0.01 | -0.01 |
| EPS Diluted Continuous Ops | -0.01 | 0.00 | 0.00 | -0.01 | -0.01 |
| EBITDA(a) | $-1,731 | $-1,187 | $-1,924 | $-2,528 | $-2,454 |